
Metagenomi is a gene editing company committed to developing potentially curative therapeutics by leveraging a proprietary toolbox of next-generation gene editing systems to accurately edit DNA where current technologies cannot.
Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms.
We adapt and forge these naturally evolved systems into powerful therapeutic tools that can be leveraged by partners and fuel our own pipeline of novel medicines. Our goal is to revolutionize gene editing for the benefit of patients around the world.

Team Members

Aaron Lin, PhD
Sr. Scientist

Greg Cost
Sr. Director of Genome Editing
